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Abstract
Background: Unlike other malignancies, there is no literature supporting the accuracy of medical claims
data for identifying surgical treatments among patients with kidney cancer. We sought to validate
externally a previously published Medicare-claims-based algorithm for classifying surgical treatments
among patients with early-stage kidney cancer. To achieve this aim, we compared procedure assignments
based on Medicare claims with the type of surgery specified in SEER registry data and clinical operative
reports.
Methods: Using linked SEER-Medicare data, we calculated the agreement between Medicare claims and
SEER data for identification of cancer-directed surgery among 6,515 patients diagnosed with early-stage
kidney cancer. Next, for a subset of 120 cases, we determined the agreement between the claims
algorithm and the medical record. Finally, using the medical record as the reference-standard, we
calculated the sensitivity, specificity, and positive and negative predictive values of the claims algorithm.
Results: Among 6,515 cases, Medicare claims and SEER data identified 5,483 (84.1%) and 5,774 (88.6%)
patients, respectively, who underwent cancer-directed surgery (observed agreement = 93%, κ = 0.69, 95%
CI 0.66 – 0.71). The two data sources demonstrated 97% agreement for classification of partial versus
radical nephrectomy (κ = 0.83, 95% CI 0.81 – 0.86). We observed 97% agreement between the claims
algorithm and clinical operative reports; the positive predictive value of the claims algorithm exceeded 90%
for identification of both partial nephrectomy and laparoscopic surgery.
Conclusion: Medicare claims represent an accurate data source for ascertainment of population-based
patterns of surgical care among patients with early-stage kidney cancer.
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The introduction of partial nephrectomy (also called kid-
ney-sparing surgery) and laparoscopy (also called mini-
mally-invasive surgery) changed the paradigm for surgical
management of patients with early-stage kidney cancer in
two important ways.[1] First, partial nephrectomy –
which achieves equal rates of cure while better preserving
long-term renal function – replaced radical nephrectomy
(complete excision of the tumor-bearing kidney) as the
favored treatment for patients with small renal
tumors.[2,3] Second, for many patients undergoing radi-
cal nephrectomy, laparoscopy became the recommended
surgical approach because it affords easier convalescence
than conventional incisional surgery without compromis-
ing long-term cancer control.[4]
Despite their potential benefits to patients, surgeon adop-
tion of partial nephrectomy and laparoscopy has been
gradual and assymetric, [5-7] suggesting an opportunity
to achieve population-level improvements in the quality
of surgical care for patients with kidney cancer. In an effort
to understand this protracted dissemination, we recently
used linked data from the National Cancer Institute's Sur-
veillance, Epidemiology and End Results (SEER) program
and the Centers for Medicare and Medicaid Services
(Medicare) to estimate the magnitude of surgeon- versus
patient-attributable variance in the use of partial nephrec-
tomy and laparoscopy.[7] For that study, we implemented
a Medicare-claims-based algorithm to identify and classify
the procedure received by each subject treated surgically
for early-stage kidney cancer. The claims-based algorithm
included decision-rules to resolve discrepancies between
hospital and physician procedure claims (e.g., a hospital
claim for partial nephrectomy coupled with a physician
claim for radical nephrectomy).[7]
Unlike prostate, lung, and breast cancer, [8,9]however, no
published literature supports the accuracy of claims data
for identifying surgical treatments among patients with
kidney cancer. Moreover, the initial absence of specific
administrative codes for laparoscopic kidney cancer sur-
geries presented a special challenge for claims-based
assessments of evolving surgical practice patterns. The pri-
mary goal of this study, therefore, was to validate our
Medicare-claims-based algorithm for classifying kidney
cancer surgeries by comparing procedure assignments
based on Medicare claims with the type of surgery speci-
fied in SEER registry data and actual clinical operative
reports. Our findings will, in turn, further clarify the integ-
rity of claims data as a tool for studying patterns of surgi-
cal care among patients with kidney cancer.
Methods
Identification of study cohort and development of claims 
algorithm
We sought to validate a Medicare-claims-based algorithm
for surgical procedure assignment employed in a previ-
ously-published study (referred to as the parent study)
that used linked SEER-Medicare data to study the utiliza-
tion of partial nephrectomy and laparoscopic radical
nephrectomy among Medicare beneficiaries diagnosed
with kidney cancer from 1997 through 2003.[7]SEER is a
population-based cancer registry that collects data regard-
ing incidence, treatment, and mortality. The demographic
composition, cancer incidence, and mortality trends in
the SEER registries are representative of the entire United
States population.[10]The Medicare program provides
primary health insurance for 97% of the United States
population ages ≥ 65 years. Successful linkage with Medi-
care claims is achieved for > 90% of Medicare patients
whose cancer-specific data are tracked by SEER.[11]
From the SEER data included with linked SEER-Medicare
files, we identified 6,515 eligible subjects with a new diag-
nosis of localized/regional, non-urothelial kidney cancer
(see Additional File 1). For each case in this preliminary
cohort, we searched Medicare inpatient (International
Classification of Diseases, 9th revision, Clinical Modifica-
tion (ICD-9) codes) and physician (American Medical
Association Current Procedural Terminology (CPT) and
ICD-9 codes) claims for kidney cancer-specific diagnosis
and surgical procedure codes (see Additional File 2).
Using this approach, we identified an analytic cohort
comprising 5,483 patients (84.2% of the preliminary
cohort) with Medicare claims specifying the occurrence of
cancer-directed surgical therapy (see Additional File 1).[7]
We then applied a claims-based algorithm (defined a pri-
ori) to classify the specific type of surgical therapy received
by each patient (see Additional File 3). The algorithm
included explicit rules for procedure assignment for cases
with multiple surgical claims and/or discrepancies
between the inpatient and physician claims (e.g., a hospi-
tal claim for partial nephrectomy coupled with a physi-
cian claim for radical nephrectomy). We used both direct
(CPT) and indirect (CPT and ICD-9) codes to identify
cases performed laparoscopically (see Additional Files 2
and 3). As part of this algorithm, we also ascribed a lapar-
oscopic approach to patients whose length of hospital
stay was ≤ 2 days following radical or partial nephrec-
tomy. By employing this algorithm, we assigned each case
to one of four mutually exclusive surgical categories: (1)
open radical nephrectomy (ORN); (2) open partial
nephrectomy (OPN); (3) laparoscopic radical nephrec-
tomy (LRN); (4) laparoscopic partial nephrectomy
(LPN).[7] Because we anticipated small numbers during
the specified study interval, we included patients undergo-Page 2 of 7
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quency) therapies in the partial nephrectomy cohorts.
Validation of claims algorithm
After obtaining Institutional Review Board approvals, we
undertook a two-step approach to assessing the validity of
our claims-based algorithm for kidney cancer surgical pro-
cedure assignment. First, we assessed the level of concord-
ance between Medicare claims and SEER data for
identification of cancer-directed surgery (i.e., ablative sur-
gery, partial nephrectomy, or radical nephrectomy)
among 6,515 patients in the preliminary cohort from our
parent study (see Additional File 1).[8,9] We did this by
calculating both the observed agreement between the two
data sources (i.e., the number of cases in agreement
divided by the total number of cases) and the correspond-
ing kappa statistic, which quantifies the degree of agree-
ment, adjusting for chance. We used the following scale
for assessing strength of agreement based on kappa statis-
tics: κ = 0.81–1.00 almost perfect agreement; κ = 0.61–
0.80 substantial agreement; κ = 0.41–0.60 moderate
agreement; κ = 0.21–0.40 fair agreement.[12] For cases
where cancer-directed surgery was specified in both Medi-
care claims and SEER data, we used the same approach to
assess the level of agreement between data sources for
identification of partial versus radical nephrectomies.
Using SEER data as the reference-standard, we addition-
ally calculated the sensitivity, specificity, and positive
(PPV) and negative (NPV) predictive values for the claims
algorithm (both for the identification of any cancer-
directed surgery and for the identification of partial
nephrectomies). All statistical testing was completed
using computerized software (SAS v9.1, SAS Institute,
Cary, NC).
For the second step, we collaborated with the SEER regis-
try for Los Angeles County, the Cancer Surveillance Pro-
gram (CSP) at the University of Southern California, to
carry out a medical-records-based validation of our claims
algorithm. In order to retrieve medical records, we pro-
vided the CSP with a de-identified list of patient codes for
Los Angeles cases included in the analytic cohort for the
parent study (n = 549). These 549 cases from the parent
study matched with 605 records in the CSP (for patients
treated at more than one hospital a report is collected
from each). After the initial match – and before sampling
cases – CSP staff excluded 14 LA County residents who
were diagnosed and/or treated in facilities outside of LA
County, 15 cases from facilities that are now closed, and 8
cases whose CSP records did not include a code for kidney
cancer surgery. Anticipating that future studies in this area
will employ currently-available procedure codes, we
decided a priori to stratify the remaining eligible cases
according to treatment year (2000–2003 vs 1997–1999);
CSP staff then sampled 5 cases from 2000–2003 for every
1 case from 1997–1999. CSP staff requested information
for 141 cases before successfully retrieving records for the
120 cases (22% of Los Angeles cases, 2% of the total sam-
ple from the parent study) comprising our final validation
sample (i.e., medical records were not available for 21
patients). Detailed patient characteristics for each of the
previously described cohorts and sub-cohorts are pre-
sented in Additional File 4.
Upon receipt of records from treating facilities, CSP chart
abstractors identified and photocopied the kidney cancer
surgery operative report (or the relevant hospital dis-
charge summary for one case). Next, they removed all
patient and/or provider-level identifiers, replaced these
with the corresponding unique identifiers from the parent
study, and sent the de-identified, photocopied medical
records back to UCLA for review and data abstraction.
One study author (DCM) reviewed the medical records
(operative note for 119 cases, discharge summary for 1
case) to determine the surgical procedure received by each
patient (ORN, OPN, LRN, LPN).
In analyses for the subset of cases with medical records
data, we considered the procedure specified in the opera-
tive note to be the reference-standard. We first calculated
the overall concordance or observed agreement rate
between the claims algorithm and the medical record (i.e.,
the number of cases where procedure assignment was the
same for the claims algorithm and the operative report
divided by the total number of cases in the validation
sample). We performed separate calculations for overall
procedure assignments (i.e., ORN vs OPN vs LRN vs LPN),
partial versus radical nephrectomy, and open versus lapar-
oscopic surgical approach. Finally, we calculated the sen-
sitivity, specificity, PPV and NPV of the claims algorithm
for identification of open surgery versus laparoscopy, and
partial versus radical nephrectomy.
Results
Among 6,515 Medicare beneficiaries with a new diagnosis
of localized/regional, non-urothelial kidney cancer, Medi-
care claims and SEER data identified 5,483 (84.1%) and
5,774 (88.6%) patients, respectively, who underwent can-
cer-directed surgery. For cases with both hospital and phy-
sician claims specifying the occurrence of cancer-directed
surgery, we observed 98% agreement (κ = 0.88, 95% CI
0.86 – 0.90) for classification of partial versus radical
nephrectomy, and 94% agreement (κ = 0.45, 95% CI 0.40
– 0.50) for classification of laparoscopic versus open sur-
gery.
As presented in Table 1, agreement between the two data
sources exceeded 90% (κ = 0.69, 95% CI 0.66 – 0.71). The
sensitivity of the claims algorithm for identifying the
occurrence of kidney cancer-directed surgery was 93.3%Page 3 of 7
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97.9%–98.6%) (Table 1). Among the 5,389 cases where
both the claims algorithm and SEER data specified the
occurrence of cancer-directed surgery, we observed 97%
agreement between data sources for classification of par-
tial versus radical nephrectomy (κ = 0.83, 95% CI 0.81 –
0.86) (Table 2).
Among the 120 subjects whose medical records were
reviewed, 100 (83%) and 20 (17%) underwent surgery in
2000–2003 and 1997–1999, respectively. The claims-
based algorithm correctly classified the specific surgical
procedure for 116 of 120 cases (observed agreement =
96.7%) (Table 3). The four misclassified cases include the
following: 1) one case classified as an open radical
nephrectomy was actually a laparoscopic radical nephrec-
tomy; 2) one case classified as a laparoscopic radical
nephrectomy was actually an open radical nephrectomy
(although it had started as a laparoscopic case before the
surgeon converted to conventional open surgery); 3) one
case classified as a laparoscopic radical nephrectomy was
actually a laparoscopic partial nephrectomy; and 4) one
case classified as a laparoscopic partial nephrectomy was
actually a percutaneous ablative procedure (for analytic
purposes we assigned this case to the open partial
nephrectomy group since the misclassification was based
only on surgical approach). For the single case where we
reviewed only the hospital discharge summary, both the
claims algorithm and the medical record specified an
open partial nephrectomy.
Tables 4 and 5 compare case classifications based on the
claims algorithm and operative reports for partial vs radi-
cal nephrectomy and for laparoscopic vs open surgery,
Table 1: Agreement between claims algorithm and SEER data for receipt of cancer-directed surgery among patients with kidney 
cancer
RECEIPT OF SURGERY BASED ON MEDICARE CLAIMS
No Yes Total
RECEIPT OF SURGERY BASED ON SEER 
CANCER-DIRECTED SURGERY VARIABLE
No 647 94 741
Yes 385 5389 5774
Total 1032 5483 6515
Observed agreement = 92.6%
Kappa = 0.69 (0.66–0.71)
Sensitivity† = 93.3% (92.7%–94.0%)
Specificity† = 87.3% (84.7%–89.6%)
Positive Predictive Value† = 98.3% (97.9%–98.6%)
Negative Predictive Value† = 62.7% (59.7%–65.7%)
† Calculations based on SEER cancer-directed surgery variable as the reference-standard
Table 2: Agreement between claims algorithm and SEER data for identification of partial versus radical nephrectomy
PROCEDURE BASED ON MEDICARE CLAIMS
Partial Nephrectomy Radical Nephrectomy Total
PROCEDURE BASED ON SEER CANCER-
DIRECTED SURGERY VARIABLE
Partial Nephrectomy 495 86 581
Radical Nephrectomy 88 4720 4808
Total 583 4806 5389
Observed agreement = 96.8%
Kappa = 0.83 (0.81–0.86)
Sensitivity† = 85.2% (82.0%–88.0%)
Specificity† = 98.2% (97.7%–98.5%)
Positive Predictive Value† = 84.9% (81.7%–87.7%)
Negative Predictive Value† = 98.2% (98.0%–98.6%)
† Calculations are for identification of partial nephrectomies based on SEER cancer-directed surgery variable as the reference-standardPage 4 of 7
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90% for identification of both partial nephrectomy (Table
4) and laparoscopic (Table 5) surgeries.
Discussion
Administrative and tumor registry data are useful tools for
researchers interested in the delivery and outcomes of can-
cer care. For instance, linked SEER-Medicare data can be
used to study population-based trends in cancer screen-
ing, diagnosis, treatment, and survivorship among Medi-
care beneficiaries in the United States.[11] In this study,
we evaluated the validity of Medicare claims for determin-
ing the type of surgical therapy received by patients with
early-stage kidney cancer. We report three principal find-
ings. First, we observed substantial agreement (κ = 0.69)
between Medicare claims and SEER registry data for the
identification of cancer-directed surgery among patients
with early-stage kidney cancer. Second, our claims-based
algorithm assigned the correct surgical procedure (ORN,
OPN, LRN, or LPN) for 97% of the subset of cases for
whom we performed medical record review. Third, our
claims algorithm demonstrated a high positive predictive
value for identification of partial nephrectomy (PPV 94%)
and laparoscopic kidney cancer surgeries (PPV 92%). The
consequent inference is that Medicare claims represent an
accurate data source for ascertainment of population-
based patterns of surgical care among patients with early-
stage kidney cancer.
Our findings augment existing literature that describes the
fidelity of claims data for evaluating practice patterns in
surgical oncology.[8,13] Prior work has demonstrated
good agreement between SEER and Medicare claims for
identification of patients undergoing major surgical resec-
tions for breast, colorectal, endometrial, lung, pancreatic
or prostate cancer.[8] Moreover, medical record reviews
have confirmed the high sensitivity and positive predic-
tive value of Medicare claims for detection of patients
Table 3: Agreement between claims algorithm and operative reports for specific kidney cancer surgical procedures
PROCEDURE BASED ON OPERATIVE REPORT
LPN OPN LRN ORN Total
PROCEDURE BASED ON MEDICARE CLAIMS LPN 2 1* 0 0 3
OPN 0 14 0 0 14
LRN 1 0 8 1 10
ORN 0 0 1 92 93
Total 3 15 9 93 120
Observed agreement = 96.7%
*This case actually represents a percutaneous ablation of a kidney tumor; however, for analytic purposes, we classified it as an open partial 
nephrectomy since the misclassification was based on surgical approach
Table 4: Agreement between claims algorithm and operative reports for partial versus radical nephrectomy
PROCEDURE BASED ON OPERATIVE REPORT
Partial Nephrectomy Radical Nephrectomy Total
PROCEDURE BASED ON MEDICARE 
CLAIMS
Partial Nephrectomy 16 1 17
Radical Nephrectomy 1 102 103
Total 17 103 120
Observed agreement = 98.3%
Sensitivity† = 94.1% (71.3%–99.9%)
Specificity† = 99.0% (94.7%–99.9%)
Positive Predictive Value† = 94.1% (71.3%–99.9%)
Negative Predictive Value† = 99.0% (94.7%–99.9%)
† Calculations are for identification of partial nephrectomies based on the operative report (medical record) as the reference-standardPage 5 of 7
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ectomy.[13]Data from the current study suggest that
Medicare claims can also be used to classify accurately
patients undergoing partial or radical nephrectomy for
kidney cancer (by either an open or laparoscopic
approach). The ability to distinguish laparoscopic from
open surgical cases is particularly relevant since these data
are not routinely available from the SEER registries.
Accordingly, medical claims (available from Medicare and
other payers) represent a valid and reliable source of data
for monitoring – at a national level – the impact of ongo-
ing initiatives that seek to increase surgeons' use of partial
nephrectomy and laparoscopy.
Our study has several limitations. First, the small sample
size for the medical record validation may raise concerns
about the generalizability of our findings for the greater
population of Medicare beneficiaries with kidney cancer.
Second, because CSP abstractors were unable to locate
medical records for some patients, it is possible that we
have overestimated the concordance between the claims
algorithm and surgeon operative notes. Third, energy
ablative therapies (i.e., cryosurgery and radiofrequency
ablation) are now used more frequently as alternatives to
partial nephrectomy. Because we anticipated (and
observed) very small numbers of these cases in the parent
study, we included ablative therapies with the partial
nephrectomies. In the future, updated claims algorithms
may be needed to separately identify patients treated with
ablative therapies. Finally, the generalizability of our
results may be limited by a sample that includes only
patients ≥ 66 years of age at the time of diagnosis. We do
not believe, however, that patterns of treatment are sys-
tematically different for 65-year-olds versus older Medi-
care beneficiaries ages 66 and older.
Conclusion
Despite these limitations, this study confirms a high level
of agreement between Medicare claims and clinical oper-
ative reports for the identification of specific kidney can-
cer surgeries. Claims data, therefore, may be considered a
valid substrate for studying patterns of surgical care
among patients with kidney cancer.
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